| Name |
Tf Antigen: Fmoc-Ser(Galβ(1-3)GalNAc)-OH (Peracetate)
|
|---|
| Product No. | GA121010 |
|---|
| Synonym(s) |
Tf Epitope (Serine); T Antigen (Serine,Fmoc, Peracetylated); Thomsen–Friedenreich Antigen; Core 1 Glycan (Serine); Fmoc-L-Ser(Galβ(1-3)GalNAc)-OH (Peracetate); Fmoc-Ser[β-Gal(Ac)₄-(1-3)-α-GalNAc(Ac)₂]-OH; O-{2-N-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-4,6-di-O-acetyl-2-deoxy-α-D-galactopyranosyl}-N α-(fluoren-9-yl-methoxycarbonyl)-L-Serine
|
|---|
| Category | Glycoamino AcidsSerine |
|---|
| CAS No. | 125760-30-7 |
|---|
| Formula | C44H52N2O21 |
|---|
| Molecular Weight | 944.88 |
|---|
| Availability | Yes |
|---|
| Availability in Bulk | Yes |
|---|
| Purity | >95% (HPLC) |
|---|
| Description | Tumor-Associated Carbohydrate Antigen (TACA). TF is a truncated O-glycosylated core determinant (Core 1) with structure: Galβ1-3GalNAcα-O-Ser/Thr. In normal Mamalian cells, the TF determinant is masked by larger glycan residues. Once unmasked, TF serves as an important recognition element, mediating several cell-cell interactions. As such, TF is implicated in tumour cell organotropic metastasis. Targeting immune responses to truncated variants of O-glycan chains expressed by tumour cells represents a promising approach for the development of antigen-specific therapeutic vaccines against cancers, and accumulated evidence has rendered TF a potential target for cancer immunotherapy. |
|---|
| Comments | N-Acetyl-D-Galactosamine; O-Link; Disaccharide; Serine; Blocked; Amino Acid; Ac |
|---|
| References | F.J. Irazoqui et al., Immunology and Cell Biology 2005, 83, 405–415 |
|---|
| Datasheet(s) | GA121010_COA.pdf (84.147 KB)
|
|---|
